RSS Feed
Biogen Idec Offers 2010 Guidance: BioBuzz
Company forecasts 2010 earnings that exceed Street expectations.
07:50AM 02/09/10
FDA Tough on Cell Therapeutics' Cancer Drug
Investors were warned last week about problems with Cell Therapeutics' cancer drug pixantrone.
12:29PM 02/08/10
FDA Raises Concerns About Cell Therapeutics' Cancer Drug
Ahead of a Feb. 10 advisory panel meeting, regulators say pivotal trial of pixantrone was too small; they also express concern about heart safety of drug.
09:46AM 02/08/10
AMAG Defends Feraheme Safety: BioBuzz
AMAG Pharmaceuticals used a Friday evening conference call to swat down safety concerns about its intravenous iron replacement therapy Feraheme.
07:04AM 02/08/10
Biotech Stock Mailbag: Soligenix
Our biotech columnist answers readers' burning questions about Soligenix, Cell Therapeutics, and other biotech stocks.
07:00AM 02/05/10
AMAG Pharma Tumbles on Feraheme Safety Concerns: BioBuzz
Analyst downgrade AMAG citing Feraheme patients experiencing severe allergic reactions.
12:15PM 02/04/10
Alkermes Testing its Version of Popular Schizophrenia Drug
Ahead of its Q4 earnings report due after the bell, Alkermes announced that it is starting testing of aripiprazole, a top-selling schizophrenia treatment.
08:31AM 02/04/10
10 Biotech Stocks on Clinical Trials Watch
News of clinical trial results can make or break a drug. Here are ten companies expected to announce important results in coming months.
06:00AM 02/04/10
Medivation's Alzheimer Trial Data in Early March: Biobuzz
Phase III study of Dimebon could be make or break for Medivation's stock price.
10:42AM 02/02/10
Biotech Calendar: Key Dates for February
February's list of important, potentially stock-moving biotech events.
06:00AM 02/02/10
Connect with TheStreet